Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 48: 1437-1444, 2002;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (116)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Katzmann, J. A.
Right arrow Articles by Kyle, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Katzmann, J. A.
Right arrow Articles by Kyle, R. A.
Related Collections
Right arrow Clinical Immunology
Right arrow Proteomics and Protein Markers
Right arrow Hematology
(Clinical Chemistry. 2002;48:1437-1444.)
© 2002 American Association for Clinical Chemistry, Inc.

Serum Reference Intervals and Diagnostic Ranges for Free {kappa} and Free {lambda} Immunoglobulin Light Chains: Relative Sensitivity for Detection of Monoclonal Light Chains

Jerry A. Katzmann1a, Raynell J. Clark1, Roshini S. Abraham1, Sandra Bryant1, James F. Lymp1, Arthur R. Bradwell2 and Robert A. Kyle1

1 Mayo Clinic, 200 First St. SW, Rochester, MN 55905.

2 The Binding Site Ltd and The Medical School, University of Birmingham, Birmingham B15 2TT, England.

aAddress correspondence to this author at: Mayo Clinic, Hilton Bldg., Room 920, 200 First St. SW, Rochester, MN 55905. Fax 507-266-4088; e-mail katzmann{at}mayo.edu.

Background: The detection of monoclonal free light chains (FLCs) is an important diagnostic aid for a variety of monoclonal gammopathies and is especially important in light-chain diseases, such as light-chain myeloma, primary systemic amyloidosis, and light-chain-deposition disease. These diseases are more prevalent in the elderly, and assays to detect and quantify abnormal amounts of FLCs require reference intervals that include elderly donors.

Methods: We used an automated immunoassay for FLCs and sera from a population 21–90 years of age. We used the calculated reference and diagnostic intervals to compare FLC results with those obtained by immunofixation (IFE) to detect low concentrations of monoclonal {kappa} and {lambda} FLCs in the sera of patients with monoclonal gammopathies.

Results: Serum {kappa} and {lambda} FLCs increased with population age, with an apparent change for those >80 years. This trend was lost when the FLC concentration was normalized to cystatin C concentration. The ratio of {kappa} FLC to {lambda} FLC (FLC K/L) did not exhibit an age-dependent trend. The diagnostic interval for FLC K/L was 0.26–1.65. The 95% reference interval for {kappa} FLC was 3.3–19.4 mg/L, and that for {lambda} FLC was 5.7–26.3 mg/L. Detection and quantification of monoclonal FLCs by nephelometry were more sensitive than IFE in serum samples from patients with primary systemic amyloidosis and light-chain-deposition disease.

Conclusions: Reference and diagnostic intervals for serum FLCs have been developed for use with a new, automated immunoassay that makes the detection and quantification of monoclonal FLCs easier and more sensitive than with current methods. The serum FLC assay complements IFE and allows quantification of FLCs in light-chain-disease patients who have no detectable serum or urine M-spike.




The following articles in journals at HighWire Press have cited this article:


Home page
 JCOHome page
O. Landgren, J. J. Goedert, C. S. Rabkin, W. H. Wilson, K. Dunleavy, R. A. Kyle, J. A. Katzmann, S. V. Rajkumar, and E. A. Engels
Circulating Serum Free Light Chains As Predictive Markers of AIDS-Related Lymphoma
J. Clin. Oncol., February 10, 2010; 28(5): 773 - 779.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
H.-T. Tsai, N. E. Caporaso, R. A. Kyle, J. A. Katzmann, A. Dispenzieri, R. B. Hayes, G. E. Marti, M. Albitar, P. Ghia, S. V. Rajkumar, et al.
Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: a prospective study
Blood, December 3, 2009; 114(24): 4928 - 4932.
[Abstract] [Full Text] [PDF]

Home page
 haematolHome page
I. I. van Gameren, M. H. van Rijswijk, J. Bijzet, E. Vellenga, and B. P. Hazenberg
Histological regression of amyloid in AL amyloidosis is exclusively seen after normalization of serum free light chain
Haematologica, August 1, 2009; 94(8): 1094 - 1100.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. J. Bakker, A. Bierma-Ram, C. Elderman-van der Werf, M. L. Strijdhaftig, and J. J. van Zanden
Quantitation of Serum Free Light Chains
Clin. Chem., August 1, 2009; 55(8): 1585 - 1587.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. M. Giarin, L. Giaccone, R. Sorasio, C. Sfiligoi, B. Amoroso, F. Cavallo, A. Cipriani, A. Palumbo, and M. Boccadoro
Serum Free Light Chain Ratio, Total {kappa}/{lambda} Ratio, and Immunofixation Results Are Not Prognostic Factors after Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma
Clin. Chem., August 1, 2009; 55(8): 1510 - 1516.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
J. A. Katzmann, R. A. Kyle, J. Benson, D. R. Larson, M. R. Snyder, J. A. Lust, S. V. Rajkumar, and A. Dispenzieri
Screening Panels for Detection of Monoclonal Gammopathies
Clin. Chem., August 1, 2009; 55(8): 1517 - 1522.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. P. Piehler and P. Urdal
In Reply
Clin. Chem., August 1, 2009; 55(8): 1587 - 1588.
[Full Text] [PDF]

Home page
 Am J Clin PatholHome page
A. Legg, J. A. R. Hobbs, G. P. Mead, A. R. Bradwell, S. Davern, and A. Solomon
Monoclonal vs Polyclonal Free Light Chain Assays
Am J Clin Pathol, June 1, 2009; 131(6): 901 - 902.
[Full Text] [PDF]

Home page
 Lab MedHome page
E. J.D. Robson, J. Taylor, C. Beardsmore, S. Basu, G. Mead, and T. Lovatt
Utility of Serum Free Light Chain Analysis When Screening for Lymphoproliferative Disorders: The Experience at a District General Hospital in the United Kingdom
Lab Med, June 1, 2009; 40(6): 325 - 329.
[Full Text] [PDF]

Home page
 Lab MedHome page
D. Siegel, E. Bilotti, and K. H. van Hoeven
Serum Free Light Chain Analysis for Diagnosis, Monitoring, and Prognosis of Monoclonal Gammopathies
Lab Med, June 1, 2009; 40(6): 363 - 366.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
O. Landgren, R. A. Kyle, R. M. Pfeiffer, J. A. Katzmann, N. E. Caporaso, R. B. Hayes, A. Dispenzieri, S. Kumar, R. J. Clark, D. Baris, et al.
Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
Blood, May 28, 2009; 113(22): 5412 - 5417.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
C. A. Hutchison, A. R. Bradwell, M. Cook, K. Basnayake, S. Basu, S. Harding, J. Hattersley, N. D. Evans, M. J. Chappel, P. Sampson, et al.
Treatment of Acute Renal Failure Secondary to Multiple Myeloma with Chemotherapy and Extended High Cut-Off Hemodialysis
Clin. J. Am. Soc. Nephrol., April 1, 2009; 4(4): 745 - 754.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
G. Palladini, P. Russo, T. Bosoni, L. Verga, G. Sarais, F. Lavatelli, M. Nuvolone, L. Obici, S. Casarini, S. Donadei, et al.
Identification of Amyloidogenic Light Chains Requires the Combination of Serum-Free Light Chain Assay with Immunofixation of Serum and Urine
Clin. Chem., March 1, 2009; 55(3): 499 - 504.
[Abstract] [Full Text] [PDF]

Home page
 Am J Clin PatholHome page
J. M. Abadie, K.H. van Hoeven, and J. M. Wells
Are Renal Reference Intervals Required When Screening for Plasma Cell Disorders With Serum Free Light Chains and Serum Protein Electrophoresis?
Am J Clin Pathol, February 1, 2009; 131(2): 166 - 171.
[Abstract] [Full Text] [PDF]

Home page
 Lab MedHome page
F. H. Wians Jr
Use of Excel Spreadsheets to Create Interpretive Reports for Laboratory Tests Requiring Complex Calculations
Lab Med, January 1, 2009; 40(1): 5 - 12.
[Full Text] [PDF]

Home page
 BloodHome page
A. D. Wechalekar, H. J. Lachmann, H. J. B. Goodman, A. Bradwell, P. N. Hawkins, and J. D. Gillmore
AL amyloidosis associated with IgM paraproteinemia: clinical profile and treatment outcome
Blood, November 15, 2008; 112(10): 4009 - 4016.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
J. A. Katzmann and A. Dispenzieri
Screening Algorithms for Monoclonal Gammopathies
Clin. Chem., November 1, 2008; 54(11): 1753 - 1755.
[Full Text] [PDF]

Home page
 CJASNHome page
C. A. Hutchison, S. Harding, P. Hewins, G. P. Mead, J. Townsend, A. R. Bradwell, and P. Cockwell
Quantitative Assessment of Serum and Urinary Polyclonal Free Light Chains in Patients with Chronic Kidney Disease
Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1684 - 1690.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. P. Piehler, N. Gulbrandsen, P. Kierulf, and P. Urdal
Quantitation of Serum Free Light Chains in Combination with Protein Electrophoresis and Clinical Information for Diagnosing Multiple Myeloma in a General Hospital Population
Clin. Chem., November 1, 2008; 54(11): 1823 - 1830.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Dispenzieri, L. Zhang, J. A. Katzmann, M. Snyder, E. Blood, R. DeGoey, K. Henderson, R. A. Kyle, M. M. Oken, A. R. Bradwell, et al.
Appraisal of immunoglobulin free light chain as a marker of response
Blood, May 15, 2008; 111(10): 4908 - 4915.
[Abstract] [Full Text] [PDF]

Home page
 haematolHome page
T. Bochtler, U. Hegenbart, C. Heiss, A. Benner, F. Cremer, M. Volkmann, J. Ludwig, J. B. Perz, A. D. Ho, H. Goldschmidt, et al.
Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis
Haematologica, March 1, 2008; 93(3): 459 - 462.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Dispenzieri, R. A. Kyle, J. A. Katzmann, T. M. Therneau, D. Larson, J. Benson, R. J. Clark, L. J. Melton III, M. A. Gertz, S. K. Kumar, et al.
Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma
Blood, January 15, 2008; 111(2): 785 - 789.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. Daval, A. Tridon, N. Mazeron, J.-M. Ristori, and B. Evrard
Risk of Antigen Excess in Serum Free Light Chain Measurements
Clin. Chem., November 1, 2007; 53(11): 1985 - 1986.
[Full Text] [PDF]

Home page
 haematolHome page
E. Kastritis, A. Anagnostopoulos, M. Roussou, S. Toumanidis, C. Pamboukas, M. Migkou, A. Tassidou, I. Xilouri, S. Delibasi, E. Psimenou, et al.
Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone
Haematologica, October 1, 2007; 92(10): 1351 - 1358.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
A. Jaccard, P. Moreau, V. Leblond, X. Leleu, L. Benboubker, O. Hermine, C. Recher, B. Asli, B. Lioure, B. Royer, et al.
High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis
N. Engl. J. Med., September 13, 2007; 357(11): 1083 - 1093.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
P.-X. Wang and P. W. Sanders
Immunoglobulin Light Chains Generate Hydrogen Peroxide
J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1239 - 1245.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
C. A. Hutchison, P. Cockwell, S. Reid, K. Chandler, G. P. Mead, J. Harrison, J. Hattersley, N. D. Evans, M. J. Chappell, M. Cook, et al.
Efficient Removal of Immunoglobulin Free Light Chains by Hemodialysis for Multiple Myeloma: In Vitro and In Vivo Studies
J. Am. Soc. Nephrol., March 1, 2007; 18(3): 886 - 895.
[Abstract] [Full Text] [PDF]

Home page
 haematolHome page
U. Mosbauer, F. Ayuk, H. Schieder, M. Lioznov, A. R. Zander, and N. Kroger
Monitoring serum free light chains in patients with multiple myeloma who achieved negative immunofixation after allogeneic stem cell transplantation
Haematologica, February 1, 2007; 92(2): 275 - 276.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. D. Wechalekar, H. J. B. Goodman, H. J. Lachmann, M. Offer, P. N. Hawkins, and J. D. Gillmore
Safety and efficacy of risk-adapted cyclophosphamide, thalidomide, and dexamethasone in systemic AL amyloidosis
Blood, January 15, 2007; 109(2): 457 - 464.
[Abstract] [Full Text] [PDF]

Home page
 Annals of Clinical & Laboratory ScienceHome page
I. Ramasamy
Serum Free Light Chain Analysis in B-cell Dyscrasias
Ann. Clin. Lab. Sci., January 1, 2007; 37(3): 291 - 294.
[Full Text] [PDF]

Home page
 Ann Rheum DisHome page
J-E Gottenberg, F Aucouturier, J Goetz, C Sordet, I Jahn, M Busson, J-M Cayuela, J Sibilia, and X Mariette
Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome
Ann Rheum Dis, January 1, 2007; 66(1): 23 - 27.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. Blade
Monoclonal Gammopathy of Undetermined Significance
N. Engl. J. Med., December 28, 2006; 355(26): 2765 - 2770.
[Full Text] [PDF]

Home page
 Mayo Clin Proc.Home page
J. A. Katzmann, A. Dispenzieri, R. A. Kyle, M. R. Snyder, M. F. Plevak, D. R. Larson, R. S. Abraham, J. A. Lust, L. J. Melton III, and S. V. Rajkumar
Elimination of the Need for Urine Studies in the Screening Algorithm for Monoclonal Gammopathies by Using Serum Immunofixation and Free Light Chain Assays
Mayo Clin. Proc., December 1, 2006; 81(12): 1575 - 1578.
[Abstract] [Full Text] [PDF]

Home page
 CJASNHome page
V. Sanchorawala
Light-Chain (AL) Amyloidosis: Diagnosis and Treatment
Clin. J. Am. Soc. Nephrol., November 1, 2006; 1(6): 1331 - 1341.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
D. Dingli, R. A. Kyle, S. V. Rajkumar, G. S. Nowakowski, D. R. Larson, J. P. Bida, M. A. Gertz, T. M. Therneau, L. J. Melton III, A. Dispenzieri, et al.
Immunoglobulin free light chains and solitary plasmacytoma of bone
Blood, September 15, 2006; 108(6): 1979 - 1983.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
J. A. Katzmann
Serum Free Light Chain Specificity and Sensitivity: A Reality Check
Clin. Chem., September 1, 2006; 52(9): 1638 - 1639.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
P. G. Hill, J. M. Forsyth, B. Rai, and S. Mayne
Serum Free Light Chains: An Alternative to the Urine Bence Jones Proteins Screening Test for Monoclonal Gammopathies
Clin. Chem., September 1, 2006; 52(9): 1743 - 1748.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
G. Palladini, F. Lavatelli, P. Russo, S. Perlini, V. Perfetti, T. Bosoni, L. Obici, A. R. Bradwell, G. M. D'Eril, R. Fogari, et al.
Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL
Blood, May 15, 2006; 107(10): 3854 - 3858.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Dispenzieri, M. Q. Lacy, J. A. Katzmann, S. V. Rajkumar, R. S. Abraham, S. R. Hayman, S. K. Kumar, R. Clark, R. A. Kyle, M. R. Litzow, et al.
Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation
Blood, April 15, 2006; 107(8): 3378 - 3383.
[Abstract] [Full Text] [PDF]

Home page
 Annals of Clinical & Laboratory ScienceHome page
J. M. Abadie and D. D. Bankson
Assessment of serum free light chain assays for plasma cell disorder screening in a veterans affairs population.
Ann. Clin. Lab. Sci., March 1, 2006; 36(2): 157 - 162.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
T. D. Jaskowski, C. M. Litwin, and H. R. Hill
Detection of {kappa} and {lambda} Light Chain Monoclonal Proteins in Human Serum: Automated Immunoassay versus Immunofixation Electrophoresis
Clin. Vaccine Immunol., February 1, 2006; 13(2): 277 - 280.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. L. Donato, A. M. Feasel, D. M. Weber, V. G. Prieto, S. A. Giralt, R. E. Champlin, and M. Duvic
Scleromyxedema: role of high-dose melphalan with autologous stem cell transplantation
Blood, January 15, 2006; 107(2): 463 - 466.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. R. Nowrousian, D. Brandhorst, C. Sammet, M. Kellert, R. Daniels, P. Schuett, M. Poser, S. Mueller, P. Ebeling, A. Welt, et al.
Serum Free Light Chain Analysis and Urine Immunofixation Electrophoresis in Patients with Multiple Myeloma
Clin. Cancer Res., December 15, 2005; 11(24): 8706 - 8714.
[Abstract] [Full Text] [PDF]

Home page
 Arch DermatolHome page
M. Q. Lacy, W. J. Hogan, M. A. Gertz, A. Dispenzieri, S. V. Rajkumar, S. Hayman, S. Kumar, M. R. Litzow, and A. L. Schroeter
Successful Treatment of Scleromyxedema With Autologous Peripheral Blood Stem Cell Transplantation
Arch Dermatol, October 1, 2005; 141(10): 1277 - 1282.
[Abstract] [Full Text] [PDF]

Home page
 Mayo Clin Proc.Home page
S. V. Rajkumar and R. A. Kyle
Multiple Myeloma: Diagnosis and Treatment
Mayo Clin. Proc., October 1, 2005; 80(10): 1371 - 1382.
[Abstract] [PDF]

Home page
 CirculationHome page
R. H. Falk
Diagnosis and Management of the Cardiac Amyloidoses
Circulation, September 27, 2005; 112(13): 2047 - 2060.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
J. A. Viedma, N. Garrigos, and S. Morales
Comparison of the Sensitivity of 2 Automated Immunoassays with Immunofixation Electrophoresis for Detecting Urine Bence Jones Proteins
Clin. Chem., August 1, 2005; 51(8): 1505 - 1507.
[Full Text] [PDF]

Home page
 BloodHome page
S. V. Rajkumar, R. A. Kyle, T. M. Therneau, L. J. Melton III, A. R. Bradwell, R. J. Clark, D. R. Larson, M. F. Plevak, A. Dispenzieri, and J. A. Katzmann
Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance
Blood, August 1, 2005; 106(3): 812 - 817.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
A. R. Bradwell
Serum Free Light Chain Measurements Move to Center Stage
Clin. Chem., May 1, 2005; 51(5): 805 - 807.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
J. A. Katzmann, R. S. Abraham, A. Dispenzieri, J. A. Lust, and R. A. Kyle
Diagnostic Performance of Quantitative {kappa} and {lambda} Free Light Chain Assays in Clinical Practice
Clin. Chem., May 1, 2005; 51(5): 878 - 881.
[Abstract] [Full Text] [PDF]

Home page
 ASH Education BookHome page
S. V. Rajkumar
MGUS and Smoldering Multiple Myeloma: Update on Pathogenesis, Natural History, and Management
Hematology, January 1, 2005; 2005(1): 340 - 345.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
J. R. Tate, D. Gill, R. Cobcroft, and P. E. Hickman
Practical Considerations for the Measurement of Free Light Chains in Serum
Clin. Chem., August 1, 2003; 49(8): 1252 - 1257.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. S. Abraham, M. C. Charlesworth, B. A.L. Owen, L. M. Benson, J. A. Katzmann, C. B. Reeder, and R. A. Kyle
Trimolecular Complexes of {lambda} Light Chain Dimers in Serum of a Patient with Multiple Myeloma
Clin. Chem., October 1, 2002; 48(10): 1805 - 1811.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Association for Clinical Chemistry.